growth and differentiation of hepatocytes.
were studied morphologically by immunohistochemical staining for c-kit and cluster of differentiation 34 (CD34), which are both markers of hepatic tissue stem cells , as well as cytokeratin 19 (CK19 ), a marker of biliary cells.
Methods
Of 17 patients with hepatitis fulminant or serious liver disorder who underwent a hepatobiopsy at Showa University Hospital during the period from 1997 to 2000, 16 patients from whom additional specimens were available (22 specimens from needle biopsy and 1 specimen from wedge biopsy) were studied. Five patients suffering from chronic hepatitis C with a transaminase activity below 300 acted as controls (New Inuyama Classification : 2 patients for A 1 and 3 patients for A3, [Modified HAI Score" Grading < 13]) . The hepatic tissue samples were fixed in formalin, then processed for paraffin embedding and sectioned for staining by hematoxylin and eosin (H & E) to assess the severity of the liver damage in accordance with the New Inuyama Classification and Modified HAI Score . Areas of tissue containing no hepatocytes or severely degenerated hepatocytes (for example , hydropic degeneration or Councilman bodies) were defined as the affected areas, and the remaining hepatic tissue with no apparent damage was defined as the non-affected area . The ratio of the affected area to non-affected area was referred to as the disorder rate. This morphological assessment was carried out on high-magnification (X40 objective lens) , H & E-stained images, which were imaged using an Olympus DP70 microscope.
The appearance of c-kit+CD34+cells was determined by immunostaining according to the EnVision + method. Day 1 was defined as the day on which maximal transaminase activity was measured; the period from day 1 to 14 was defined as the early stage of the liver disorder, and the period from day 15 onwards comprised the late stage . The primary antibodies used were as follows : a rabbit polyclonal anti-human CD 117 c-kit antibody (DAKO, diluted 1 in 200) ; a mouse monoclonal (clone QBEnd 10) anti-human CD34 Class II hematopoietic progenitor cells antibody (DAKO, diluted 1 in 200) ; and a mouse monoclonal (clone b170) anti-human NCL-CK 19 antibody (Novocastra , diluted 1 in 100). Various immunostaining patterns have been reported for the c-kit receptor2'3.
In the present study, cells positive for cytoplasmic staining, or nuclear staining, or staining of both cytoplasm and nucleus were counted as positive cells in accordance with a report by DiMatteo, et a12)For CD34, cells with cell membrane and/or cytoplasmic staining were judged as positive. For CK19, cells with a diffuse staining of the cytoplasm were assessed as positive.
The number of c-kit-positive cells (c-kit + cells) and CD34-positive cells (CD34+cells) appearing in the specimens over the course of the disorder according to the time-periods defined above were counted, with the number of positive cells per 1 mm2 defined as the appearance rate. The affected area was equally divided into three concentric circular areas from the center of damage to the margin; the internal 2/3 of the affected area was defined as the central area and the outer 1/3 of the affected area as the border area. In addition, c-kit+CD34+cells detected inside the hepatic vessels were counted as vascular c-kit + CD34+ cells, as distinct from the peribiliary c-kit + CD34+ cells , which were those detected near regenerated biliary ducts or on regenerated biliary endothelium. Both the disorder rate and the appearance rate of c-kit + CD34 + cells were studied in patients with either serious liver disorder or chronic hepatitis. Differences in the appearance rate and appearance time of the underlying disease were studied in patients with severe liver disorder , Appearance of c-kit+CD34+cells in Severe and related to the rate and time of appearance of the c-kit +CD34+cells. A hepatitis C virus carrier who underwent a hepatobiopsy prior to complications of acute myeloid leukemia (M3) was excluded from the investigation of appearance time because hepatic function was found to be aggravated even after the hepatobiopsy. The relationship between the rate and time of appearance of the peribiliary c-kit+CD34+cells was also studied. Differences in the data were tested for significance using the t-test.
Results
In patients with a serious liver disorder, H & E staining showed infiltration of inflammatory cells, most of which were lymphocytes, into the affected area. However, it was difficult to identify hepatic tissue stem cells such as oval cells (approximately 10 ,um in diameter) morphologically ( Fig. la) . Immunostaining indicated that both c-kit+cells and CD34+ce1ls appeared with a similar incidence and in the same affected area as the isolated oval cells, which were identified by a high nucleolar/nuclear ratio (Figs. lb and c). In addition, CD34 staining detected some positive sinusoidal endothelial cells (Fig. lc) . In patients with chronic hepatitis, few c-kit+CD34+cells were detected in the affected areas (Fig. ld) .
The appearance rate of c-kit+CD34+cells was significantly higher in the patients with serious liver disorder (p<0.01) compared to those with chronic hepatitis ( Table 1 ). The underlying disease in patients with serious liver damage was alcoholic liver disease (ALD) , HB + ALD (n =1), acute myeloid leukemia (AML (M3) + HB) (n =1), viral hepatitis A (HA) (n =1) and autoimmune hepatitis (AIH) (n= 1). The appearance rate of c-kit+CD34+cells was conspicuously high in the patient with HB+ALD, with no significant difference between patients with the other diseases ( Table 2 ).
The appearance rate of c-kit + CD34 + cells showed no significant difference between the early and late stages of the disease (Table 3 ). However, the appearance rate in the affected areas was high in comparison with the non-affected areas, regardless of the stage of the disease ( Table 4 ). The appearance rate of c-kit+CD34+cells within the affected areas in the Appearance of c-kit)CD34)cells in Severe Liver Damage Table 4 . c-kit'CD34'cell incidence in areas with and without liver disorder (n=22) **p<0
. Table 5 . c-kit)CD34)cell incidence in central and border areas of an area of disorder (n=22) **p<0 .01 early stage was significantly higher (p<0.01) in the central areas than in the border areas ( Fig. 2a) , although in the late stage of the disease, it appeared to be higher in the border areas (Fig. 2b) . This result indicated a temporal and spatial relationship between appearance rate of c-kit+CD34+cells and stage of the disease ( Table 5 ). C-kit+CD34+ cells appeared around the biliary ducts both in the early and late stages ( Figs. 3a and b ) and were partially included in the biliary constituent cells in some patients (Fig. 3c) . In one patient, c-kit 'CD34 'cells were detected inside and outside the portal vein in the early stage (Fig. 3d) .
These peribiliary cells appeared to account for the higher, although not significantly different rate of c-kit'CD34'cells in the late stage, compared to the rate in the early stages (Table 6 ). No correlation was found between the number of regenerated biliary ducts and the number of peribiliary c-kit +CD34+cells. Oval cells are a type of hepatic tissue stem cell that can differentiate into hepatocytes and biliary cells. They are found around the interlobular bile duct and Herring duct in normal liver, and express cell-surface markers such as c-kit, CD34, cytokeratins 7, 8, 14, 18, and 19, vimentin, OV6, OC 2 and 3, GGT, AFP, albumin and Thy-1. In contrast, myeloid stem cells, which are multipotent and autoreproductive, can differentiate into skeletal muscled, cardiac muscles, vascular endothelium6), nerve', and intestinal endothelial cells'). It was found recently that bone marrow contains hepatic stem cells (precursor cells able tc differentiate into oval, cells or hepatocytes) [9] [10] [11] [12] [13] [14] , and this prompted interest in what roles Appearance of c-kit+CD34+cells in Severe Liver Damage these cells might be playing.
The c-kit protein is expressed in mast cells, melanocytes, and mammary endothelial cells15). The c-kit protein contains KIT, which is a transmembrane receptor of 145 to 156 kDa with tyrosine kinase activity. KIT is composed of an extracellular ligand-binding domain of immunoglobulin-like 5'-repeat sequences, a transmembrane domain, a juxtamembrane domain, and an intracellular domain with tyrosine kinase activity, and shows homology to the PDF and M-CSF receptors'b). Ligands that bind to KIT include stem cell factor (SCF) and master cell growth factor. SCF binding induces dimer formation, which activates tyrosine kinase, and induces cellular growth and differentiation.
The oval cells isolated in this study were found to express both c-kit and CD34, consistent with hepatic tissue stem cells, suggesting that the c-kit + CD34 + cells are able to grow and differentiate through the action of c-kit. The present study showed that the appearance rate of c-kit+CD34+cells was significantly higher in all patients with serious liver disorder. The appearance rate in the defined affected areas was significantly higher than that in the non-affected areas. Furthermore, in one patient, c-kit + CD34 + cells were detected both inside and outside the vessels (portal vein) in an affected area. The results suggested that the liver is an organ with sufficient autoreproductivity to repair damage with the aid of hepatocytes or hepatic tissue stem cells in patients with chronic hepatitis. However, c-kit + CD34+ cells are supplied from the extrahepatic tissues in patients with extensive damage that surpasses the autoreproductive ability of the hepatocytes when even the hepatic tissue stem cells may be damaged. We speculate that these extrahepatocytes were supplied to the liver via the peripheral circulation; this speculation is consistent with a report by Petersen, et a19)that hepatic stem cells derived from bone marrow are transferred to the liver. The c-kit+CD34+cells were found to appear early in the course of the liver damage, but showed no significant difference in numbers between early and late stages of the disorder. This indicated that once delivered to the liver, the c-kit+CD34+cells remain there throughout the course of the disorder to aid in liver regeneration.
C-kit+CD34+cells appeared in all hepatic areas both in the early and late stages of the disease, but the appearance rate of c-kit+CD34+cells was significantly higher (p<0.01) in the central affected areas in comparison with the border areas, and tended to be higher in the border areas in the late stage compared to the early stage. The appearance rate in the central areas appeared to be higher in the early stage, but no difference was seen between the early and late stages in the border areas. In addition, the appearance rate of peribiliary c-kit+CD34+cells appeared to be higher in the late rather than the early stages, although this difference was not significant. In addition, the appearance rate was higher in the border areas and around the biliary ducts in the late stage in comparison with the early stage, suggesting that c-kit+CD34+cells appear in the early stage in the central areas then move to the border areas and the surrounding areas of the biliary ducts over time to where oval cells may be present in normal liver. It was therefore speculated that c-kit +CD34+ cells migrate into the normal site of oval cells to transdifferentiate into hepatocytes or peribiliary cells needed for liver regeneration. The results of this study are consistent with those in a report by Petersen, et al9) that oval cells delivered from organs other than the liver transdifferentiate into hepatocytes or biliary cells under particular physiopathological conditions. This is also consistent with the streaming liver theory" that, as the site where 
